Simplex Trading’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $70.1K | Sell |
15,574
-6,629
| -30% | -$29K | ﹤0.01% | 5494 |
|
|
2025
Q4 | $107K | Sell |
22,203
-18,760
| -46% | -$84.4K | ﹤0.01% | 4934 |
|
|
2025
Q3 | $185K | Buy |
40,963
+18,988
| +86% | +$69.7K | ﹤0.01% | 5027 |
|
|
2025
Q2 | $67K | Sell |
21,975
-14,154
| -39% | -$47K | ﹤0.01% | 5620 |
|
|
2025
Q1 | $126K | Buy |
36,129
+16,222
| +81% | +$54.1K | ﹤0.01% | 4816 |
|
|
2024
Q4 | $65K | Sell |
19,907
-45,387
| -70% | -$167K | ﹤0.01% | 5584 |
|
|
2024
Q3 | $251K | Sell |
65,294
-30,239
| -32% | -$116K | ﹤0.01% | 4298 |
|
|
2024
Q2 | $295K | Buy |
95,533
+7,403
| +8% | +$22.2K | ﹤0.01% | 4244 |
|
|
2024
Q1 | $227K | Sell |
88,130
-16,330
| -16% | -$42.3K | ﹤0.01% | 4704 |
|
|
2023
Q4 | $261K | Buy |
104,460
+79,069
| +311% | +$155K | ﹤0.01% | 4386 |
|
|
2023
Q3 | $51K | Sell |
25,391
-3,502
| -12% | -$7.34K | ﹤0.01% | 5775 |
|
|
2023
Q2 | $66K | Buy |
28,893
+23,963
| +486% | +$62.4K | ﹤0.01% | 5531 |
|
|
2023
Q1 | $14K | Sell |
4,930
-41,080
| -89% | -$116K | ﹤0.01% | 7227 |
|
|
2022
Q4 | $107K | Buy |
46,010
+5,454
| +13% | +$13K | ﹤0.01% | 4989 |
|
|
2022
Q3 | $77K | Sell |
40,556
-88,835
| -69% | -$209K | ﹤0.01% | 5867 |
|
|
2022
Q2 | $350K | Sell |
129,391
-423
| -0.3% | -$1.08K | ﹤0.01% | 3895 |
|
|
2022
Q1 | $386K | Sell |
129,814
-72,149
| -36% | -$221K | ﹤0.01% | 4201 |
|
|
2021
Q4 | $785K | Buy |
201,963
+171,920
| +572% | +$668K | ﹤0.01% | 3201 |
|
|
2021
Q3 | $94K | Buy |
30,043
+249
| +0.8% | +$830 | ﹤0.01% | 6700 |
|
|
2021
Q2 | $90K | Buy |
29,794
+13,839
| +87% | +$42.9K | ﹤0.01% | 6873 |
|
|
2021
Q1 | $0 | Sell |
15,955
-101,280
| -86% | -$391K | ﹤0.01% | 8633 |
|
|
2020
Q4 | $416K | Buy |
+117,235
| New | +$410K | ﹤0.01% | 3667 |
|
|
2020
Q1 | – | Sell |
-43,344
| Closed | -$117K | – | 7495 |
|
|
2019
Q4 | $120K | Buy |
43,344
+42,925
| +10,245% | +$69.5K | ﹤0.01% | 4315 |
|
|
2019
Q3 | $0 | Sell |
419
-252
| -38% | -$434 | ﹤0.01% | 7153 |
|
|
2019
Q2 | $1K | Buy |
+671
| New | +$1.72K | ﹤0.01% | 6836 |
|
|
2018
Q4 | – | Sell |
-7,700
| Closed | -$37.9K | – | 6890 |
|
|
2018
Q3 | $72K | Sell |
7,700
-1,851
| -19% | -$18.4K | ﹤0.01% | 4772 |
|
|
2018
Q2 | $69K | Buy |
9,551
+2,520
| +36% | +$15K | ﹤0.01% | 4706 |
|
|
2018
Q1 | $35K | Buy |
7,031
+4,238
| +152% | +$22.4K | ﹤0.01% | 2777 |
|
|
2017
Q4 | $14K | Buy |
+2,793
| New | +$16.4K | ﹤0.01% | 3614 |
|
|
2017
Q3 | – | Sell |
-1,914
| Closed | -$8.19K | – | 5785 |
|
|
2017
Q2 | $6K | Buy |
1,914
+1,005
| +111% | +$3.46K | ﹤0.01% | 4389 |
|
|
2017
Q1 | $2K | Sell |
909
-53,618
| -98% | -$149K | ﹤0.01% | 5187 |
|
|
2016
Q4 | $133K | Buy |
54,527
+33,389
| +158% | +$97.2K | 0.01% | 1317 |
|
|
2016
Q3 | $72K | Buy |
21,138
+14,028
| +197% | +$54.8K | ﹤0.01% | 1803 |
|
|
2016
Q2 | $24K | Buy |
7,110
+1,249
| +21% | +$5.29K | ﹤0.01% | 2723 |
|
|
2016
Q1 | $24K | Buy |
5,861
+3,226
| +122% | +$11.5K | ﹤0.01% | 2626 |
|
|
2015
Q4 | $11K | Sell |
2,635
-2,658
| -50% | -$14.6K | ﹤0.01% | 3186 |
|
|
2015
Q3 | $32K | Sell |
5,293
-7,451
| -58% | -$66.1K | ﹤0.01% | 2330 |
|
|
2015
Q2 | $151K | Buy |
12,744
+4,097
| +47% | +$62.3K | 0.01% | 949 |
|
|
2015
Q1 | $150K | Buy |
+8,647
| New | +$177K | 0.02% | 852 |
|
Other funds holding ABUS
TSC
WCM
VCM
RCMNY
ACM
Simplex Trading's ABUS Position: Q1 2026 in Review
Simplex Trading reduced its Arbutus Biopharma (ABUS) stake by 30% in Q1 2026, selling an estimated $29K and leaving 15,574 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5494.
Simplex Trading first reported a position in ABUS in Q1 2015 and has held it in 39 quarters since. The position peaked at $785K in Q4 2021. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.
- Simplex Trading held 15,574 shares of Arbutus Biopharma worth $70.1K as of Q1 2026.
- Simplex Trading sold 6,629 Arbutus Biopharma shares in Q1 2026, an estimated $29K.
- Arbutus Biopharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5494 holding.
- Simplex Trading first reported a position in Arbutus Biopharma in Q1 2015 and has held it in 39 quarters since.
- Simplex Trading's Arbutus Biopharma position peaked at $785K in Q4 2021.
- 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.